TD Cowen Upgrades GoodRx Holdings to Outperform, Raises Price Target to $12
Portfolio Pulse from richadhand@benzinga.com
TD Cowen analyst Charles Rhyee has upgraded GoodRx Holdings (NASDAQ:GDRX) from Market Perform to Outperform and raised the price target from $6.5 to $12.
July 31, 2023 | 10:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GoodRx Holdings has been upgraded to Outperform by TD Cowen, with a raised price target of $12. This could potentially lead to an increase in the stock's price.
The upgrade from Market Perform to Outperform by TD Cowen indicates a positive outlook for GoodRx Holdings. The raised price target from $6.5 to $12 suggests that the analyst believes the stock is undervalued at its current price, which could lead to an increase in the stock's price as the market adjusts to this new information.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100